Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

@article{Nicola2002HumanBM,
  title={Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.},
  author={M. Di Nicola and C. Carlo-Stella and M. Magni and M. Milanesi and P. Longoni and P. Matteucci and S. Grisanti and A. Gianni},
  journal={Blood},
  year={2002},
  volume={99 10},
  pages={
          3838-43
        }
}
CD2(+) T lymphocytes obtained from either the donor of bone marrow stromal cells (BMSCs) or a third party were cultured in mixed lymphocyte reactions (MLRs) with either allogeneic dendritic cells (DCs) or peripheral blood lymphocytes (PBLs). When autologous or allogeneic BMSCs were added back to T cells stimulated by DCs or PBLs, a significant and dose-dependent reduction of T-cell proliferation, ranging from 60% +/- 5% to 98% +/- 1%, was evident. Similarly, addition of BMSCs to T cells… Expand
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.
TLDR
Findings indicate that powerful regulatory CD4+ or CD8+ lymphocytes are generated in co-cultures of PBMC with MSC, which strongly suggests that these regulatory cells may amplify the reported MSC-mediated immunosuppressive effect. Expand
Human bone marrow stromal cells hamper specific interactions of CD4 and CD8 T lymphocytes with antigen-presenting cells.
TLDR
Morphological observations of the cocultures showed impairment of physical interactions between T-cell and antigen-presenting cells in the presence of BMSC, with lack of formation of antigen-dependent clusters of T cells and antigen, presenting cells (APCs). Expand
Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
TLDR
Phenotypic analysis indicated that CD8(+)Reg(c) are CD25(+)CD28(+) and express low levels of mRNA for Foxp3 but they do not bear CTLA4 and glucocorticoid-induced tumor necrosis factor receptor antigens, indicating that the molecular mechanism of CD8 (+)Reg (c)-mediated regulation is independent of the function of CSA biochemical target molecules. Expand
Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15
TLDR
There is a dichotomous effect of MSCs/ACs on lymphocytes proliferating in response to the homeostatic IL2, IL7 and IL15 cytokines likely to be encountered in homeostatics and autoimmune inflammatory conditions. Expand
Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation.
TLDR
Using Jurkat cells as a model of leukemia T cells, results indicated an uncertainty about the suppressive effect of MSCs and their inhibitory metabolites on tumor or leukemia cell proliferation. Expand
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway
TLDR
Bone marrow mesenchymal progenitor cells are used for regenerating tissues of mesodermal origin, as well as tissues of different embryological derivation and the possibility of their therapeutic application in transplantation and autoimmune diseases is asserted. Expand
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
TLDR
It is concluded that MSCs can initiate activation of alloreactive T cells, but do not elicit T cell proliferative responses due to active suppressive mechanisms. Expand
Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.
TLDR
It is found that CD14+ monocytes from blood activate MSCs to secrete inhibitory molecules that lead to inhibition of alloreactive T cells, which represents a unique immune regulatory paradigm that can potentially be exploited in clinic. Expand
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
TLDR
The findings indicate that MSCs escape recognition by CTLs and alloreactive NK cells, and inhibit the formation of cytotoxic T cells by secreting a soluble factor, but that they do not interfere with C TLs and NK cell lysis. Expand
Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells
TLDR
It is confirmed that MSCs strongly inhibited proliferation of CD8+ T cells in a mixed lymphocyte reaction, and also suppressed proliferation of T cells specifically recognizing cytomegalovirus (CMV) and influenza virus. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro.
TLDR
The collective results may provide new mechanistic insight into why B-cell recovery is delayed post-BMT and underscore the importance of VCAM-1/CD106 in regulating B lymphopoiesis. Expand
Comparative studies of different stromal cell microenvironments in support of human B-cell development.
TLDR
It is concluded that human BM stromal cell, human skin fibroblasts, and murine S17 stromaal cell cultures can provide complementary and comparative tools for identification of stromAL cell ligands with potentially unique functions in regulating human B-cell development. Expand
Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development.
TLDR
These experiments suggest that effects of androgens on developing B cells are mediated through androgen receptors in bone marrow stromal cells, and TGF-beta is a candidate mediator for these hormonal effects. Expand
Adhesion molecules involved in the interactions between early T cells and mesenchymal bone marrow stromal cells.
TLDR
Comparison between the interaction of T cells with bone marrow mesenchymal or with thymus-derived epithelial stroma indicated that T cells utilize a selected set of adhesion molecules under each situation. Expand
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation.
TLDR
M marrow stromal progenitors reinfused in patients receiving a sex-mismatched, T-cell-depleted allograft have a limited capacity of reconstituting marrow mesenchymal cells. Expand
Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: A role of stromal cells in positive selection.
TLDR
It is suggested that stromal cells can migrate from the bone marrow to the thymus, where they participate in the positive selection of thymocytes, as shown in mice that received bone marrow cells plus bones. Expand
Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo.
TLDR
Observations indicate that CD10 may represent a reliable marker for identifying and isolating apoptosing T cells in vitro and ex vivo and possibly suggest novel functions for surface CD10 in the apoptotic process of lymphoid cells. Expand
Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity.
TLDR
It is concluded that during the first year after transplantation, the absence of an immune response is due mainly to the loss of an adequate T-cell repertoire. Expand
Host origin of marrow stromal cells following allogeneic bone marrow transplantation
TLDR
Using in situ hybridization to discriminate donor cells from host in blood and bone marrow samples obtained from patients with functioning sex-mismatched but HLA-identical allografts, marrow-derived stromal cells that proliferate in long-term cultures were found to be of host genotype, whereas the macrophage component of the adherent layer in these cultures originated from the donor. Expand
Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.
TLDR
A phase I trial to determine the feasibility of collection, ex vivo culture-expansion and intravneous infusion of human bone marrow-derived progenitor stromal cells (MPCs) obtained from cancer patients found they can be collected, expanded in vitro and infused intravenously without toxicity. Expand
...
1
2
3
4
5
...